Comparative studies concerning the tumour inhibition and the toxicology of vinblastine and vincristine
Németh, L.; Somfai, S.; Gál, F.; Kellner, B.
Neoplasma 17(4): 345-347
1970
ISSN/ISBN: 0028-2685 PMID: 5506441 Document Number: 29747
Document emailed within 1 workday
Related Documents
Smith, S.R.; Thomas, D.B.; Riches, A.C. 1972: Metaphase accumulation in tumour isografts following the administration of colcemid, vinblastine or vincristine Journal of Anatomy 111(Part 3): 480Howard, S.M.; Theologides, A.; Sheppard, J.R. 1980: Comparative effects of vindesine, vinblastine, and vincristine on mitotic arrest and hormonal response of L1210 leukemia cells Cancer Research 40(8 Part 1): 2695-2700
Tsuruo, T.; Iida, H.; Tsukagoshi, S.; Sakurai, Y. 1981: Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil Cancer Research 41(5): 1967-1972
Chohan, V.; Lowenthal, R.M. 1982: Effect of vinblastine, vincristine, and vindesine on neutrophil phagocytosis and iodination Cancer Treatment Reports 66(3): 505-508
Krishan, A.; Frei, E. 1975: Morphological basis for the cytolytic effect of vinblastine and vincristine on cultured human leukemic lymphoblasts Cancer Research 35(3): 497-501
Jordan, M.A.; Himes, R.H.; Wilson, L. 1985: Comparison of the effects of vinblastine, vincristine, vindesine, and vinepidine on microtubule dynamics and cell proliferation in vitro Cancer Research 45(6): 2741-2747
Stolinsky, D.C.; Hum, G.J.; Jacobs, E.M.; Solomon, J.; Bateman, J.R. 1973: Clinical trial of weekly doses of vinblastine (NSC-49842) combined with vincristine (NSC-67574) in malignant lymphomas and other neoplasms Cancer ChemoTherapy Reports 57(4): 477-480
Ray, P.K.; De, B.K.; Guha, S.; Saha, S.; Raychaudhuri, S. 1980: Facilitation and/or inhibition of growth of sarcoma-180 ascites tumour by BCG: effects of BCG on tumour cell membrane Indian Journal of Experimental Biology 18(2): 123-128
Bezwoda, W.R.; Rastogi, R.B. 1994: A randomized comparative study of cyclophosphamide, vincristine, doxorubicin, and prednisolone and cyclophosphamide, vincristine, mitoxantrone, and prednisolone regimens in the treatment of intermediate- and high-grade lymphoma with 8 years' follow-up Seminars in Hematology 31(2 Suppl 3: 3
Johnston, C.I.; Fabris, B.; Yamada, H.; Mendelsohn, F.A.; Cubela, R.; Sivell, D.; Jackson, B. 1989: Comparative studies of tissue inhibition by angiotensin converting enzyme inhibitors Journal of Hypertension. Suppl: Official Journal of the International Society of Hypertension 7(5): S11-S16
Azizuddin; Saima Rasheed, S.R.; Naz, S.; Naheed, S.; Choudhary, M.I. 2015: Comparative anti-glycation and α-glucosidase inhibition studies of microbial transformed compounds of dydrogesterone Pakistan Journal of Pharmaceutical Sciences 28(2): 521-523
Derkach, K.V.; Shpakov, A.O.; Uspenskaia, Z.I.; Kuznetsova, L.A. 2009: Inhibition of the adenylyl cyclase signaling system by colchicine and vinblastine in ciliate Dileptus anser Tsitologiia 51(12): 1013-1018
Donahoe, J.P.; Kleven, S.H.; Eidson, C.S. 1978: Studies on resistance to Marek's disease tumorigenesis: effect of immune stimulation, tumour-cell vaccines, and herpesvirus of turkeys on tumour immunity Iarc Scientific Publications 1978(24 Part 2): 1037-1041
Szentirmay, Z.; Gyeskó, A.; Sugár, J. 1973: Quantitative cytochemical investigations of Ehrlich ascites tumour cells treated with vincristine. 3. Polarization microscopic investigations Neoplasma 20(1): 31-35
Yamazaki, H.; Shimada, T. 1998: Comparative studies of in vitro inhibition of cytochrome P450 3A4-dependent testosterone 6beta-hydroxylation by roxithromycin and its metabolites, troleandomycin, and erythromycin Drug Metabolism and Disposition: the Biological Fate of Chemicals 26(11): 1053-1057
Weisburger, J.H.; Jones, R.C. 1989: Nutritional toxicology: on the mechanisms of inhibition of formation of potent carcinogens during cooking Progress in Clinical and Biological Research 304: 377-390
McKay, D.B.; Schneider, A.S. 1984: Selective inhibition of cholinergic receptor-mediated 45Ca++ uptake and catecholamine secretion from adrenal chromaffin cells by taxol and vinblastine Journal of Pharmacology and Experimental Therapeutics 231(1): 102-108
Komarnicki, M.; Balcerzak, A.; Górski, P.; Pawlak, L.; Hansz, J. 1994: Treatment outcome of advanced Hodgkin's disease based on using an alternating program ChLVPP (chlorambucil, vinblastine, procarbazine, prednisone) and ABV (doxorubicin, bleomycin, vinblastine) Acta Haematologica Polonica 25(4): 363-368
Gus'kova, T.A.; Berliand, E.A.; Popova, V.N.; Romanova, L.K.; Chicherina, L.A. 1984: Comparative study of dioxidine and quinoxidine in a chronic toxicology experiment Farmakologiia i Toksikologiia 47(1): 104-109
Potier, P.; Guénard, D.; Zavala, F. 1979: Recent results in the field of vinblastine group antitumour alkaloids. Biochemical studies Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 173(2): 414-424